顯示第 1 至 16 項結果,共 50 項
-
Anti-alpha 5 beta 1 Integrin [M200 (Volociximab)] (Ab00449-13.0-BT)
-
Anti-alpha 5 beta 1 Integrin [M200 (Volociximab)] (Ab00449-13.0)
-
Anti-C5 [Eculizumab] (Ab00296-25.0-BT)
-
Anti-C5 [Eculizumab] (Ab00296-25.0)
-
Anti-carcinoembryonic antigen (CEA) [Arcitumomab] (Ab00281-10.0-BT)
-
Anti-carcinoembryonic antigen (CEA) [Arcitumomab] (Ab00281-10.0)
-
Anti-CD11a [hu1124 (Efalizumab)] (Ab00535-10.3-BT)
-
Anti-CD11a [hu1124 (Efalizumab)] (Ab00535-10.3)
-
Anti-CD20 [10F381 (rituximab)] (Ab00126-10.0-BT)
-
Anti-CD20 [10F381 (rituximab)] (Ab00126-10.0)
-
Anti-CD3 epsilon [OKT-3 (muromonab)] (Ab00122-2.0-BT)
-
Anti-CD3 epsilon [OKT-3 (muromonab)] (Ab00122-2.0)
-
Anti-CD40L [hu5c8 (Ruplizumab)] (Ab00447-10.0-BT)
-
Anti-CD40L [hu5c8 (Ruplizumab)] (Ab00447-10.0)
-
Anti-CD52 [Campath-1H] (Ab00124-10.0-BT)
-
Anti-CD52 [Campath-1H] (Ab00124-10.0)
